AI capex is ramping up among major hyperscalers as they significantly increase their investments. Read what this means for ...

Celldex has a strong cash position with a runway of 13-14 quarters, bolstered by a $424 million secondary offering in March 2024. Learn more on CLDX stock here.

Global X AIQ ETF is a top buy with strong performance and diverse holdings, outperforming peers LRNZ and THNQ. Click here to ...

Lindt & Sprüngli remains resilient amid rising cocoa prices, with organic revenue up 7.8% in FY 2024. Find out what justifies ...

OliX Pharmaceuticals announced a global licensing agreement with Eli Lilly (LLY). This collaboration focuses on the development and ...

The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...

Alphabet reported mixed Q4 earnings. Click here to read why GOOG stock is becoming a no-brainer in my view and upgraded to ...

Silicon Labs' 1Q25 guidance indicates accelerating growth, with 7% sequential and 67% y/y revenue growth. See why I upgrade ...

CNX Resources' stock drop due to hedging strategy and tax credit rulings, impacting future cash flow in rising natural gas ...

A legendary investor is selling MLPs, marking a shift in midstream sentiment. Read why I’m sharing my current take on the ...

Explore here for Alphabet's agentic AI advancements, open-source models challenging big tech, and the implications for ...

Société Générale's saw impressive Q4 results, strong CIB performance, and potential profit drivers, making it an undervalued ...